D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 43 Citations 7,014 134 World Ranking 3349 National Ranking 159

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Antibody

His primary areas of study are Immunology, Antigen, Antibody, Immune system and Immunotherapy. His study in the fields of Epitope and ELISPOT under the domain of Immunology overlaps with other disciplines such as Mannan and Antibody titer. Geoffrey A. Pietersz interconnects Molecular biology, Antigen presentation and Fusion protein in the investigation of issues within Antigen.

His Antibody study deals with Cytotoxic T cell intersecting with Cellular immunity. His work is dedicated to discovering how Immune system, Cell biology are connected with Mannosylation and other disciplines. His work focuses on many connections between Monoclonal antibody and other disciplines, such as Cancer, that overlap with his field of interest in Rheumatoid arthritis, Receptor, Inflammation, Fc receptor and Drug.

His most cited work include:

  • Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors (527 citations)
  • Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. (244 citations)
  • Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond (231 citations)

What are the main themes of his work throughout his whole career to date?

Geoffrey A. Pietersz spends much of his time researching Immunology, Antigen, Antibody, Monoclonal antibody and Molecular biology. His work on Immune system, CD8, Dendritic cell and Immunoconjugate as part of general Immunology research is often related to Mannan, thus linking different fields of science. His Immune system research incorporates themes from Inflammation and Cell biology.

His research integrates issues of Cytotoxic T cell, Antigen presentation, Mannose and Immunotherapy in his study of Antigen. His Monoclonal antibody study integrates concerns from other disciplines, such as Cancer, Cancer research, In vitro and In vivo. His study looks at the relationship between Molecular biology and topics such as Peptide sequence, which overlap with Fc receptor.

He most often published in these fields:

  • Immunology (40.18%)
  • Antigen (37.44%)
  • Antibody (36.07%)

What were the highlights of his more recent work (between 2013-2021)?

  • Antigen (37.44%)
  • Immune system (27.40%)
  • Cancer research (21.00%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Antigen, Immune system, Cancer research, Immunotherapy and Immunology. His Antigen research is multidisciplinary, relying on both Cytotoxic T cell, Antibody and Pathology. Geoffrey A. Pietersz has researched Antibody in several fields, including Binding protein and Drug.

His Immune system research includes elements of Inflammation, C-reactive protein and Apoptosis. His work investigates the relationship between Immunotherapy and topics such as Dendritic cell that intersect with problems in Cancer immunotherapy, Mannose receptor, Antigen Targeting, Ex vivo and Adenocarcinoma. His study on Immunology is mostly dedicated to connecting different topics, such as In vivo.

Between 2013 and 2021, his most popular works were:

  • Polymorphisms and Interspecies Differences of the Activating and Inhibitory FcγRII of Macaca nemestrina Influence the Binding of Human IgG Subclasses (30 citations)
  • Dendritic cell immunotherapy: clinical outcomes. (27 citations)
  • Dendritic cell immunotherapy: clinical outcomes. (27 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

His primary scientific interests are in Antigen, Dendritic cell, Immunotherapy, Ex vivo and Antigen Targeting. His Antigen study combines topics from a wide range of disciplines, such as Hematopoietic stem cell transplantation, Chemotherapy, Monomethyl auristatin E, Lymph node and Positron emission tomography. His biological study spans a wide range of topics, including Mucin, Ovarian cancer, Epithelial ovarian cancer and Adenocarcinoma.

His Immunotherapy study frequently draws connections between adjacent fields such as Pathology. His work deals with themes such as Epitope, Cancer and Molecular imaging, which intersect with Pathology. Geoffrey A. Pietersz has included themes like Mannose receptor, Immune system, Immunology and Cancer immunotherapy in his Ex vivo study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors

Theodora Fifis;Anita Gamvrellis;Blessing Crimeen-Irwin;Geoffrey A Pietersz.
Journal of Immunology (2004)

697 Citations

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

P. Mark Hogarth;P. Mark Hogarth;P. Mark Hogarth;Geoffrey A. Pietersz;Geoffrey A. Pietersz;Geoffrey A. Pietersz.
Nature Reviews Drug Discovery (2012)

350 Citations

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.

V. Karanikas;L.-A. Hwang;J. Pearson;C.-S. Ong.
Journal of Clinical Investigation (1997)

315 Citations

OXIDATIVE/REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T1 OR T2 IMMUNE RESPONSES

Vasso Apostolopoulos;Geoffrey A. Pietersz;Bruce E. Loveland;Mauro S. Sandrin.
Proceedings of the National Academy of Sciences of the United States of America (1995)

240 Citations

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Vasso Apostolopoulos;Geoffrey A Pietersz;Anastasios Tsibanis;Annivas Tsikkinis.
Breast Cancer Research (2006)

181 Citations

Cell-mediated immune responses to MUC1 fusion protein coupled to mannan

Vasso Apostolopoulos;Geoffrey A. Pietersz;Ian F.C. McKenzie.
Vaccine (1996)

178 Citations

Antibody conjugates for the treatment of cancer

Geoffrey A. Pietersz;Ian F. C. McKenzie.
Immunological Reviews (1992)

175 Citations

Mannan-MUC1 - Pulsed dendritic cell immunotherapy: A phase I trial in patients with adenocarcinoma

Bruce E Loveland;Anne Zhao;Shane C White;Hui K Gan.
Clinical Cancer Research (2006)

169 Citations

Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo

Kuo-Ching Sheng;Martha Kalkanidis;Dodie S. Pouniotis;Sandra Esparon.
European Journal of Immunology (2008)

165 Citations

Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells

Kuo-Ching Sheng;Dodie Pouniotis;Mark Dexter Wright;Choon K Tang.
Immunology (2006)

157 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Geoffrey A. Pietersz

Vasso Apostolopoulos

Vasso Apostolopoulos

Victoria University

Publications: 76

Magdalena Plebanski

Magdalena Plebanski

RMIT University

Publications: 45

P. Mark Hogarth

P. Mark Hogarth

University of Melbourne

Publications: 44

Ian F. C. McKenzie

Ian F. C. McKenzie

Austin Hospital

Publications: 22

Wolf H. Fridman

Wolf H. Fridman

Université Paris Cité

Publications: 22

Marc Daëron

Marc Daëron

Institut Pasteur

Publications: 19

Olivera J. Finn

Olivera J. Finn

University of Pittsburgh

Publications: 19

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 17

Falk Nimmerjahn

Falk Nimmerjahn

University of Erlangen-Nuremberg

Publications: 16

Sandra J. Gendler

Sandra J. Gendler

Mayo Clinic

Publications: 16

Joyce Taylor-Papadimitriou

Joyce Taylor-Papadimitriou

King's College London

Publications: 16

Istvan Toth

Istvan Toth

University of Queensland

Publications: 16

Darrell J. Irvine

Darrell J. Irvine

MIT

Publications: 15

David S. Salomon

David S. Salomon

National Institutes of Health

Publications: 14

Stephan R. Targan

Stephan R. Targan

Cedars-Sinai Medical Center

Publications: 14

Carl G. Figdor

Carl G. Figdor

Radboud University Nijmegen

Publications: 13

Trending Scientists

Rainer Leupers

Rainer Leupers

RWTH Aachen University

Jianxin Wang

Jianxin Wang

Tsinghua University

Chwee Teck Lim

Chwee Teck Lim

National University of Singapore

Ilka Wittig

Ilka Wittig

Goethe University Frankfurt

Mireille Claustres

Mireille Claustres

University of Montpellier

Arvin C. Diesmos

Arvin C. Diesmos

National Museum of Natural History

Ming-Zong Lai

Ming-Zong Lai

Academia Sinica

Angela R. McLean

Angela R. McLean

University of Oxford

Stephan C.F. Neuhauss

Stephan C.F. Neuhauss

University of Zurich

Hwan Su Yoon

Hwan Su Yoon

Sungkyunkwan University

James J. Corbett

James J. Corbett

University of Delaware

Cynthia G. Wible

Cynthia G. Wible

Harvard University

Nicolas Chomont

Nicolas Chomont

University of Montreal

Christian Brander

Christian Brander

University of Vic

Michael Winter

Michael Winter

University of Exeter

Benjamin I. Goldstein

Benjamin I. Goldstein

University of Toronto

Something went wrong. Please try again later.